Product Information
RUFINAMIDE 400 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $1.4532 per EA under NDC 59651061708. Its NADAC has been published 155 times since Sep 6, 2023.
FDA first approved this application on Jun 16, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651061708
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RUFINAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA217230FDA Approved
6/16/2023
TE Code
AB
On Market Since
6/16/2023
Price Statistics
The NADAC for RUFINAMIDE 400 MG TABLET has been published 155 times since Sep 6, 2023, and over the history we have for it it has declined 59.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4532 per EA |
|---|---|
| All-time high | $4.3216 (Oct 11, 2023) |
| All-time low | $1.3608 (May 20, 2026) |
| 52-week high | $1.7050 |
| 52-week low | $1.3608 |
| Median price | $1.8220 |
| Average price | $2.2905 |
| Largest weekly change | -38.3% (May 22, 2024) |
| Weeks tracked | 155 |
| Tracking since | Sep 6, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RUFINAMIDE 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RUFINAMIDE 400 MG TABLET, manufactured by Aurobindo Pharma Limited, is $1.4532 per EA (NDC 59651061708), effective Aug 19, 2026.
How has the price of RUFINAMIDE 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for RUFINAMIDE 400 MG TABLET has declined 59.3%. It has been tracked across 155 weekly CMS publications since Sep 6, 2023.
What are the highest and lowest recorded NADAC prices for RUFINAMIDE 400 MG TABLET?
Since Sep 6, 2023, the NADAC for RUFINAMIDE 400 MG TABLET has ranged from a low of $1.3608 (May 20, 2026) to a high of $4.3216 (Oct 11, 2023), with a median of $1.8220 per EA.
Are there cheaper alternatives to RUFINAMIDE 400 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RUFINAMIDE 400 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures RUFINAMIDE 400 MG TABLET?
RUFINAMIDE 400 MG TABLET (NDC 59651061708) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.